Home
Upcoming Webinars Archived Webinars eCongress About Xtalks Host A Webinar Contact Us Get Updates
E-mail
 photo facebookfollow_zpscb486e28.jpg

November 15, 2012

Outsourcing Cell Based Potency Assays:
Perspectives from a Sponsor and a Contract Testing Laboratory

Speakers for this Event:
  • Weihong Wang, Ph.D., manager of Molecular and Cell Biology Services, Eurofins Lancaster
        Laboratories
      
    Learn More
  • Darren Kamikura, Ph.D., Research Scientist, Eli Lilly and Co   Learn More
  • Characterization of a biological product, which includes the determination of physicochemical and immunochemical properties, biological activity, purity and related substances/impurities, is necessary to establish the safety and efficacy profile of a given product.

    Biological activity describes the specific ability, or capacity, of a product to achieve a defined biological effect. Determination of biological activity is a key requirement for biopharmaceutical products, both for lot release as well as ongoing stability programs. The development and qualification/validation of cell based potency assays is critical for measuring biological activity and ensuring consistent product quality. Due to the complex nature of biological assays, managing outsourced cell based potency assay projects can be challenging.

    This presentation will provide an overview of cell based potency assays, including current regulatory expectations as well as trends within the industry. In addition, the presentation will offer perspectives, from both a sponsor as well as a contract testing laboratory, with regard to the logistics of outsourcing cell based potency assays and will provide recommendations aimed to help biopharmaceutical companies effectively manage their outsourced programs.

    Topics will include:

    • Current regulatory expectations for cell based potency assays
    • Phase appropriate qualification/validation strategies
    • Life cycle management of cell based potency assays
    • Points to consider when working with contract testing laboratories
    THIS PROGRAM IS INTENDED FOR:

    This program is intended for scientists, managers and directors working in bioanalytical method development and quality control, for manufacturers of:

    • Monoclonal Antibodies
    • Recombinant Proteins
    • Antibody drug conjugates
    • Vaccines
    • Polypeptides
    • Biosimilars
    ABOUT OUR SPEAKERS:

    Weihong Wang, Ph.D., manager of Molecular and Cell Biology Services, Eurofins Lancaster Laboratories

    Dr. Weihong Wang is manager of Molecular and Cell Biology Services for Lancaster Laboratories where she oversees assay development/validation projects, as well as routine sample testing. She serves as a subject matter expert and direct technical contact to assist clients with testing needs and conducts QA/QC investigations to ensure successful fulfillment of business and quality metrics.

    Dr. Wang has 11 years of experience developing and characterizing biopharmaceutical products and developed extensive experience with cell and ELISA based potency assays through her previous positions at Wyeth Biopharma (currently part of Pfizer) and Johnson and Johnson Companies. Dr. Wang also participates in USP/FDA task forces, and along with her senior staff, actively monitors emergent technologies in the industry, as well as changes in regulatory expectations.

    Dr. Wang earned a Ph.D. in Cell and Molecular Biology from Brandeis University and completed postdoctoral research at Harvard Medical School.

    Darren Kamikura, Ph.D., Research Scientist, Eli Lilly and Co

    Dr. Kamikura has been developing cell based assays in the bioassay group at Lilly since 2009. Prior to joining Lilly he was at XactaGen in Seattle, WA where he studied the application of various reporters, including ß-Galactosidase and luciferases to monitor gene regulation in cell-based assays.

    Dr. Kamikura obtained bachelor’s degree from the University of British Columbia (Vancouver, Canada; 1993) in Biochemistry and Molecular Biology. He obtained his doctoral degree in Molecular Oncology at McGill University (Montreal, Canada; Ph.D. 1999) and trained as a post-doctoral fellow at the Fred Hutchinson Cancer Research Center, in Seattle, WA.

    RELATED WEBINARS

    Risk Management of Adventitious Agent Contamination in Biopharmaceutical Products
    March 21, 2012 (archive available)
    Click here for more information

    Efficient and Effective Approaches to Managing Raw Material Methods
    May 15, 2012 (archive available)
    Click here for more information

    Critical Aspects of Antibody-Drug Conjugates: Structural Characterization and Analysis
    September 25, 2012 (archive available)
    Click here for more information

    Effective Strategies for Managing Comparator Product Testing
    March 20, 2013 (archive available)
    Click here for more information

    Best Practices for Conducting Extractable and Leachable Studies
    May 22, 2013 (archive available)
    Click here for more information

    Chemistry and Microbiology Perspectives on Cleaning Validations and Disinfectant Efficacy Studies
    October 10, 2013 (archived)
    Click here for more information

    UV-C Treatment—a New Procedure for Viral Inactivation
    December 11, 2013 (archived)
    Click here for more information

    OUR XTALKS PARTNER FOR THIS EVENT:

    With a proven track record of providing quality scientific solutions for 19 of the top 20 largest pharmaceutical/biopharmaceutical companies in the world, Lancaster Laboratories is a global leader in bio/pharmaceutical laboratory services providing innovative and timely scientific solutions to streamline the drug development process.

    With facilities in Lancaster, PA, Portage, MI and Dungarvan, County Waterford, Ireland, and a global capacity of over 300,000 square feet, Lancaster Laboratories has the capabilities to meet your global regulatory requirements. All of our facilities offer cGMP-compliant laboratory services and operate under the same strict quality control program and utilize the same LIMS system.

    Our clients can choose from five service models, including our award-winning Professional Scientific Staffingand our Full Time Equivalent model to determine the most efficient and cost-effective service solution for their project. We also provide 24-hour data access via our innovative and secure online tool at LabAccess.com.

    For information about the recorded archive for this event contact Xtalks at (416) 977-6555 ext 371, or email register@xtalks.com

     
    Copyright © 2014 Honeycomb Worldwide Inc.